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INTRODUCTION
Many studies have attempted to explain the interaction of bone
tissue with various alloplastic biomaterials, such as titani-
um, that are often used to fabricate dental implants.
1,2
Improvement of the integration of biomaterials into bone
tissue is one of the challenges in the biomaterials fields. To bring
bone tissue integration on implant surfaces various tech-
niques have been used to improve tissue responses to implant
surfaces.
3-5 Many in vivo and in vitro studies have compared the
efficiency of various surface treatments in improving bone tis-
sue integration of implants.
4,6 Histological as well as bio-
chemical data from these studies describe a variety of cellular
responses to various implant surface conditions.
7-12 Many in vit-
ro evaluations of cell responses to implant roughness have been
performed in order to discern the surface properties influencing
the cell response to implant surface.
13-17 To date, compara-
tive studies regarding differences in surface composition and
topography effects on cell responses have been scarce.
Runx2 (Cbfa1) is a transcription factor that belongs to the Runx
family, and is expressed as two isoforms. Type I and II Runx
isoforms are expressed in chondrocytes, as well as osteoblasts,
although, type II Runx2 expression is predominant in
osteoblasts.
18-20 Runx2 binds to an osteoblast-specific cis-acting
element, activates the expression of osteocalcin, the most
osteoblast specific gene, and regulates osteoblast differentia-
tion and expression of key osteoblast genes necessary for
development of a mineralized phenotype. Runx2 plays an essen-
tial role in steering multipotent mesenchymal precursor cells
toward an osteoblastic lineage
21 and promotes osteoblast dif-
ferentiation at an early stage. However it inhibits osteoblast dif-
ferentiation at a late stage.
22 Runx2 is a positive regulator
that can upregulate the expression of bone matrix genes,
including type I collagen, osteopontin, bone sialoprotein
(BSP), osteocalcin, and fibronectin.
20,23,24 Lastly Runx2 was
shown to have a role beyond development and differentiation
by regulating the rate of bone matrix deposition.
23 Thus,
Runx2 is a critical gene not only for osteoblast differentiation
but also for osteoblast function. However, the effects of different
implant surface topographies on gene expression of key
osteogenic factors are not fully understood.
The hypothesis of the current study was that different
implant surface treatments differentially affect Runx2 gene
expression. Readily available Human Osteosarcoma TE-
85cells were used. In this study, cells were grown on machined,
sandblasted, anodized cpTi discs and control tissue culture plates
for 1st, 3rd, and 5th days. The purpose of this study was to
address molecular events with respect to the osteogenic key
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marker, Runx2 gene expression in relation to different implant
surface treatments. Using these samples, it is intended to
study the different effects of not only surface roughness but also
topography on osteoblast gene expression. 
MATERIAL AND METHODS
1. Cell culture and titanium disc specimens
TE-85 cells were maintained as sub-confluent monolayers in
RPMA 1640 (Gibsco BRL, Grand Island, NY, USA) supplemented
with 10% (v/v) fetal bovine serum (FBS) at 37℃. Commercially
pure titanium (cpTi) discs with dimensions of 23 mm diameter
× 1 mm height were used. The 72 discs’ surfaces were prepared
and original machined surfaces were used. Among the discs,
24 discs’ surfaces were sandblasted with 75 μ m Al2O3, while 24
other discs’ surfaces were anodized under constant voltage, 350
V. Table I shows the result of the optical interferometer
(Acura 2000, Intek Plus, Daejon, Korea) analysis. Sandblasted
surface showed rougher surface than anodized one, and
anodized surface had rougher surface than machined surface.
And surface morphologies were shown in Fig. 1. For each group,
8 titanium discs were placed on a 100 φ dish, and TE-85 cells
were cultured (1 × 10
6 cells/mL) on to titanium surfaces with
2 ml 10% FBS growth medium for 1, 3 and 5 days. 
Fig. 1. SEM (JSM-840A, JEOL, Japan) of the
machined, sandblasted and anodized surface
structures of the prepared titanium discs. 
machined surface × 500 × 3,000
sandblasted surface × 500 × 3,000
anodized surface × 500 × 3,000
Table I. Surface roughness of Ti disc samples (measured with Acura 2000)
Machined Sandblasted Anodized
Roughness (Ra) 0.6 ±0.14 1.29 ±0.15 0.85 ±0.11
Ra: arithmetic mean of the absolute values of the surface93
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2. Cell harvesting and RNA extraction
Growth media and extra cells (not attached to discs) were suc-
tioned and cells attached to the discs, then washed with PBS
solution. Cells were harvested with a hand scrapper. Total cel-
lular RNA was extracted using the RNeasy
� Protect kit
(Qiagen, Hilden, Germany), DNAse 1-treated then quantified
by measuring absorbance at λ 260 nm on a UV160U spec-
trophotometer (RB-10. Dynamica, Salzburg, Austria). For the
first strand cDNA synthesis, an initial RT mixture was treat-
ed [2 μ g total RNA, 1 mM dNTPs, 50 pmol Poly (dT)-15, 30 mM
KCl, 8 mM MgCl2, and 1 mM dithiothreitol, in 25 mM Tris-HCl]
and incubated at 65℃ for 5 minutes, then quenched on ice.
3. Reverse transcription PCR
10μ l of diluted cDNA was transferred into a 10 μ l PCR
reaction mixture that contained 5 pmol/μ l of sense and anti-
sense oligonucleotide primers, 1×PCR buffer (10 mM Tris-HCl,
50 mM KCl, 1.5 mM MgCl2), 0.1 mM dNTPs, and 0.5 U
TaqDNA polymerase. The forward primer (5-TCTGGCCT-
TCCACTCTCAGT-3) and reverse primer (5-TATG-
GAGTGCTGCTGGTCTG-3) of Runx2 were synthesized based
on the Runx2 mRNA sequence. Amplification reactions for the
Runx-2 cDNA and the house keeping gene glyceraldehydes
phosphate dehydrogenase (GAPDH) were carried out.
Amplifications were performed using an Authorized thermal
cycler (eppendorf, Mastercycler gradient, Hamburg, Germany),
with the temperature cycling being set as follows: 94℃ for 60 s,
58℃ for 30 s, 72℃ for 60 s: 5 cycles, 94℃ for 30 s 56℃ for 30 s,
72℃ for 60 s: 5 cycles, 94℃ for 30 s, 54℃ for 30 s, 72℃ for 60 s:
25 cycles, followed by a final extension at 72℃ for 10 minutes.
PCR products were analyzed by 1% agarose gel elec-
trophoresis containing 0.01% ethidium bromide. Visualized PCR
product bands were sliced from the gel and fluorescence
within the gel was detected using a Lumi-imager F1 Workstation
(Roche Molecular Biochemicals, Indianapolis, IN, USA). The
relative intensity of each band was determined and plotted as
the relative abundance of Cbfa1/GAPDH amplification prod-
uct abundance. 
RESULTS
The expression of Runx2 gene was examined using Reverse
transcription PCR and the electrophoresis result is shown in
Fig. 2. Runx2 expression differences in TE-85 cells over a 5-th
day time course with varied implant surface treatments are
shown in Fig. 3. The results demonstrate more Runx2 expres-
sion in cells grown on sandblasted surface at the first day of
culture, on anodic oxidized surface at 3-rd day of culture, on
machined surface at 5-th day of culture. The patterns of the gene
expression with different surface treatment were noted along
the time table. The Runx2 mRNA from cells cultured on the con-
trol plate increased to 3 days and at a constant level to 5
days of culture. mRNA from cells cultured on machined sur-
face discs increased consistently to 5 days. mRNA from cells
cultured on sandblasted surface discs showed highest level
expression on the first day, then remained constant during the
5-th day of culture period. mRNA from cells cultured on
anodized surface discs increased rapidly from the first day to
the third day and then slightly decreased at the fifth day of cul-
ture. 
Fig. 2. Effects of surface treatments on Runx2 mRNA expression in TE-85 cells. Ehidium bromide-stained agarose gel analysis of RT-PCR products.
p: control tissue culture plate. m: machined. a: anodic oxidized. s: sandblasted.
p m a s p m a s p m a s
└ Day 1           ┘└ Day 3            ┘└ Day 5            ┘
Table II. Values represent calculated relative intensities measured
from UV transilluminated, ethidium bromide stained gels. Values in the
parenthesis represent Runx2/GAPDH intensity (%)
PMA S
1 day GAPDH 5.56 5.67 5.62 5.12
Runx2 1.97 (35.43) 2.58 (45.5) 2.03 (36.12) 2.5 (48.82)
3 day GAPDH 5.65 5.62 5.6 5.67
Runx2 2.71 (47.96) 2.71 (48.22) 3.72 (66.42) 2.65 (46.73)
5 day GAPDH 5.67 5.67 5.57 5.08
Runx2 2.69 (47.44) 3.99 (70.37) 3.35 (60.14) 2.59 (50.98)94
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DISCUSSION
Osteoblast differentiation, ECM formation, and subsequent
mineralization are needed for bone formation associated
with osteogenesis and subsequent osseointegration. Transcription
factor Runx2 regulates this development. Osteoblast differ-
entiation and responses during osseointegration vary and
are affected by the implant surface microtopography, associated
extracellular matrix proteins, and their respective integrin
receptors.
25-29 A lot of studies in examining cell adhesion and
morphology, DNA synthesis, integrin and extracellualar
matrix expression, and enzyme activity have been done to elu-
cidate osteoblastic response to titanium alloys.
26,30-32 However,
many of the molecular and genotypic events taking place at the
osteoblast cell level during osseointegration are still largely
unknown. 
The purpose of our study was to address these molecular
events with respect to the osteogenic key marker, and Runx2
gene expression in relation to different implant surface treat-
ments. In this study, the amounts and patterns of Runx2
gene expressions were different with time according to vari-
ous surface treatments. Various hypotheses could be pro-
posed to explain these data.
Roughness increased from tissue culture plate, machined discs,
anodized discs and sandblasted discs respectively. During the
study period, levels of Cbfa1 expression increased with
increasing roughness. From this result, we could hypothesize
that the rougher the implant surface, the sooner the Runx2 gene
expresses. The early expression of Runx2 in TE-85 cells on cpTi
discs of increased surface roughness or topographic com-
plexity is congruent with in vivo observations regarding the extent
of osteogenesis on implants of increasing surface roughness.
9
The surface properties of an implant seem to influence the com-
ponents of the cell cytoskeleton involved in cell spreading and
locomotion. Another determinant of cell shape and spreading
onto a surface is the establishment of cell contacts and adhe-
sion to the surface. Cell contact and adhesion are time-depen-
dent phenomena and many studies support early spreading
of osteoblasts on rougher surfaces.
7,10 Aside from the direct effects
of the cytoskeleton, integrin-mediated signaling pathways
are known to affect gene expression, as well as increased
Runx2 gene expression was noted on rougher surfaces.
15
Another study reported that differentiation of preosteoblasts
is affected by implant surface topographies.
16 Similarly our data
indicated that early Runx2 gene expression was favored by the
rougher surface. 
Second, the expression amount of the gene should be con-
sidered. In this study the highest expression was recorded on
the machined surface at the fifth day of culture. However we
should consider not only the amount, but also the timing of
expression and the activity of Runx2. Shui et al. demonstrat-
ed that human bone marrow-derived mesenchymal stem
cells constitutively express Runx2. However there was a lack
of correlation between Runx2 mRNA or protein levels and the
acquisition of the osteoblastic phenotype in these cells.18
Franceschi et al. demonstrated that Runx2 overexpression in
immature osteoblast-like cells resulted in the acceleration
and robust up-regulation of matrix mineralization.
33 In this study
osteosarcoma TE-85cells were used, which are committed
osteoblasts that are more mature osteoblast compared to pre-
osteoblast or bone marrow stromal cell. In this cell line, early
expression and activity of Runx2 during that time could be more
meaningful. The amount of expression itself could be critical
for accelerating and enhancing osseointegration. However, addi-
tional studies about the activity of Runx2 related to surface treat-
ments in these cells are strongly recommended.
Third, the effect of not only roughness but also chemical com-
position and the characteristics of surface microstructure on
Runx2 expression should be considered. Previous studies
supported and established the effects of anodic oxidized
treatment showed improvement of osseointegration and bio-
logic responses. The microstructure along with phase and
composition of oxide layers are significantly changed by
micro arc oxidation (MAO). The concentrations of Ca or P ions
Fig. 3. a, b. Reverse transcription PCR analysis for Runx2 gene expression by TE-85 cells over time (in days). The amounts and patterns of Runx2 expres-
sions differ in time according to various surface treatments (p: tissue culture plate, m: machined, a: anodic oxidized, s: sandblasted). Values represent
Runx2/GAPDH intensity. 
a b95
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in the oxide layer are increased with the applied voltage.
6
Furthermore, the changes in chemical composition and rough-
ness of the Ti surface played crucial roles in the biocompati-
bility of the implant. Li et al. demonstrated roughness and the
amount of Ca and P ions incorporated into the titanium
oxide layer strongly affect the cell response.
6 This study
showed that different implant surface microtopographies
(machined, sandblasted, anodic oxidized) may alter the
expression of key osteogenic regulatory genes such as Runx2.
This suggests that the interaction of osteoblasts with the
extracellular matrix components on different implant sur-
face microtopographies can influence gene expression. Perhaps
this occurs as a result of differences in cell adhesion and
shape, as a result of integrin-mediated adhesion and regula-
tion of downstream signaling cascades as reported.
26 It could
also be a result of extracellular matrix spatial and temporal
expression profile changes that would appear under the con-
trol of the transcription factor Runx2, such as bone sialopro-
tein (BSP2).
20
Thus, different surface treatments may contribute to the
regulation of osteoblast differentiation by influencing the
level of gene expression of key osteogenic factors. A better under-
standing of these molecular processes will lead to the devel-
opment of more advanced therapeutic interventions associated
with dental implant therapy and tissue-engineering biologi-
cal applications. In future, we could use not only mechanical
or chemical treatment to improve osseointegration, but also gene
therapy-based strategies for bone regeneration may be achieved
using the approach of over-expressing combinations of factors
for improving the extent and type of bone formed in regenerating
sites.
CONCLUSION
Human osteosarcoma TE-85 cells were cultured on machined,
sandblasted and anodic oxidized cpTi discs. After the first, the
third, and the fifth days cells were harvested and reverse
transcription PCR was used for comparative analysis of
Runx2 gene expression to study the effect of various surface
treatments of titanium surface on the expression of Runx2 in
vitro. The results were as follows.
1. More expression of Runx2 in cells grown on sandblasted
surface at the one-day culture were observed; on anodic
oxidized surface at the three-days culture, and on machined
surface at five-days culture was noted.
2. In cells on tissue culture plates, the lowest expression
level was noted, and the level increased slightly by 3
days, and was maintained to 5 days.
3. In cells on machined cpTi discs, the expression level was
intermediate at the first day, however increased constitutively
to the fifth day.
4. In cells on sandblasted cpTi discs, the expression level was
highest in the 1 day sample and the level was main-
tained to 5 days.
5. In cells on anodized cpTi discs, the expression level
increased rapidly to 3 days, but decreased slightly in the
5 day sample.
We can conclude that different surface treatments may con-
tribute to the regulation of osteoblast differentiation by influ-
encing the level of gene expression. However, it is considered
that future studies with more controlled conditions and
experimental samples are necessary to understand the mech-
anism of cellular responses to different implant surface treat-
ments.
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